These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30442595)

  • 41. pH-responsive iron manganese silicate nanoparticles as T1-T2* dual-modal imaging probes for tumor diagnosis.
    Chen J; Zhang WJ; Guo Z; Wang HB; Wang DD; Zhou JJ; Chen QW
    ACS Appl Mater Interfaces; 2015 Mar; 7(9):5373-83. PubMed ID: 25685956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-Performance
    Zhao D; Peng S; Xiao H; Li Q; Chai Y; Sun H; Liu R; Yao L; Ma L
    ACS Appl Bio Mater; 2023 Jun; 6(6):2137-2144. PubMed ID: 37229527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
    Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silica-F127 nanohybrid-encapsulated manganese oxide nanoparticles for optimized T1 magnetic resonance relaxivity.
    Wei Hsu BY; Wang M; Zhang Y; Vijayaragavan V; Wong SY; Yuang-Chi Chang A; Bhakoo KK; Li X; Wang J
    Nanoscale; 2014 Jan; 6(1):293-9. PubMed ID: 24193096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fe
    Cha R; Li J; Liu Y; Zhang Y; Xie Q; Zhang M
    Colloids Surf B Biointerfaces; 2017 Oct; 158():213-221. PubMed ID: 28697436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. One-step preparation of nano-in-micro poly(vinyl alcohol) embolic microspheres and used for dual-modal T
    Wang Q; Xiao A; Liu Y; Zou Q; Zhou Q; Wang H; Yang X; Zheng C; Yang Y; Zhu Y
    Nanomedicine; 2018 Nov; 14(8):2551-2561. PubMed ID: 30153472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis of nanomedicines by nanohybrids conjugating ginsenosides with auto-targeting and enhanced MRI contrast for liver cancer therapy.
    Zhao X; Wang J; Song Y; Chen X
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1307-1316. PubMed ID: 29527925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fe(3)O(4)/MnO hybrid nanocrystals as a dual contrast agent for both T(1)- and T(2)-weighted liver MRI.
    Im GH; Kim SM; Lee DG; Lee WJ; Lee JH; Lee IS
    Biomaterials; 2013 Mar; 34(8):2069-76. PubMed ID: 23246062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fe
    Wang C; Yan C; An L; Zhao H; Song S; Yang S
    J Mater Chem B; 2021 Sep; 9(37):7734-7740. PubMed ID: 34586149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrasmall MnSe Nanoparticles as
    Chen SH; Huang LY; Huang B; Zhang M; Li H; Pang DW; Zhang ZL; Cui R
    ACS Appl Mater Interfaces; 2022 Mar; 14(9):11167-11176. PubMed ID: 35226454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging.
    Hu H; Dai A; Sun J; Li X; Gao F; Wu L; Fang Y; Yang H; An L; Wu H; Yang S
    Nanoscale; 2013 Nov; 5(21):10447-54. PubMed ID: 24057072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Folic acid-functionalized gadolinium-loaded phase transition nanodroplets for dual-modal ultrasound/magnetic resonance imaging of hepatocellular carcinoma.
    Maghsoudinia F; Tavakoli MB; Samani RK; Hejazi SH; Sobhani T; Mehradnia F; Mehrgardi MA
    Talanta; 2021 Jun; 228():122245. PubMed ID: 33773745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging.
    Wang G; Zhang X; Skallberg A; Liu Y; Hu Z; Mei X; Uvdal K
    Nanoscale; 2014 Mar; 6(5):2953-63. PubMed ID: 24480995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Redox-Sensitive Clustered Ultrasmall Iron Oxide Nanoparticles for Switchable T
    Ma D; Shi M; Li X; Zhang J; Fan Y; Sun K; Jiang T; Peng C; Shi X
    Bioconjug Chem; 2020 Feb; 31(2):352-359. PubMed ID: 31693856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dual modal imaging and chemotherapy of breast cancer.
    Abbasi AZ; Prasad P; Cai P; He C; Foltz WD; Amini MA; Gordijo CR; Rauth AM; Wu XY
    J Control Release; 2015 Jul; 209():186-96. PubMed ID: 25908171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity.
    Liu ZJ; Song XX; Tang Q
    Nanoscale; 2013 Jun; 5(11):5073-9. PubMed ID: 23640287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oil/water nano-emulsion loaded with cobalt ferrite oxide nanocubes for photo-acoustic and magnetic resonance dual imaging in cancer: in vitro and preclinical studies.
    Vecchione R; Quagliariello V; Giustetto P; Calabria D; Sathya A; Marotta R; Profeta M; Nitti S; Silvestri N; Pellegrino T; Iaffaioli RV; Netti PA
    Nanomedicine; 2017 Jan; 13(1):275-286. PubMed ID: 27565688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. L-EGCG-Mn nanoparticles as a pH-sensitive MRI contrast agent.
    Li J; Jiang X; Shang L; Li Z; Yang C; Luo Y; Hu D; Shen Y; Zhang Z
    Drug Deliv; 2021 Dec; 28(1):134-143. PubMed ID: 33356629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.